CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway

Yuting Wang1, Wenjie Xi1, Xinyi Zhang2

  • 1Department of Anesthesiology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Frontiers in Immunology
|January 30, 2023
PubMed
Abstract

Insights

Sepsis-induced acute kidney injury (S-AKI) involves lysosomal membrane permeabilization and Cathepsin B (CTSB) activation. Inhibiting CTSB may offer a therapeutic strategy for S-AKI.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Proteomics

Background:

  • Sepsis-induced acute kidney injury (S-AKI) is a severe complication with high mortality.
  • The underlying mechanisms of S-AKI remain complex and poorly understood.
  • Identifying S-AKI mechanisms can reveal novel therapeutic targets.

Purpose of the Study:

  • To investigate the molecular mechanisms of S-AKI.
  • To identify key proteins and pathways involved in S-AKI pathogenesis.
  • To evaluate the therapeutic potential of inhibiting Cathepsin B (CTSB) in S-AKI.

Main Methods:

  • Established a mouse model of S-AKI using cecal ligation and puncture (CLP).
  • Utilized data-independent acquisition (DIA)-mass spectrometry-based proteomics to analyze protein expression changes.
  • Created an in vitro S-AKI model using lipopolysaccharide (LPS)-treated HK-2 cells to study CTSB's role in apoptosis.

Main Results:

  • Septic mice exhibited elevated renal injury markers, increased apoptosis, and higher CTSB activity compared to controls.
  • Proteomic analysis identified 449 differentially expressed proteins, enriched in lysosomal pathways, with CTSB and MAPK as key proteins.
  • LPS-induced HK-2 cell injury involved lysosomal membrane permeabilization (LMP) and mitochondrial apoptosis pathway activation, which were reversed by CTSB inhibition (CA074).

Conclusions:

  • Lysosomal membrane permeabilization (LMP) and CTSB are critical contributors to S-AKI pathogenesis.
  • LPS-induced HK-2 cell injury is mediated by the mitochondrial apoptosis pathway.
  • Inhibition of CTSB presents a promising therapeutic strategy for mitigating S-AKI.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
47
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
53
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
51
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
55
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
39
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K